UPMC Cancer Center/Hillman Cancer Center ( Site 3017) — Pittsburgh, Pennsylvania

UPMC Cancer Center/Hillman Cancer Center ( Site 3017) is a clinical research site located in Pittsburgh, Pennsylvania, United States 15232.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

UPMC Cancer Center/Hillman Cancer Center ( Site 3017) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Carcinoma, Renal Cell.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UPMC Cancer Center/Hillman Cancer Center ( Site 3017)?

UPMC Cancer Center/Hillman Cancer Center ( Site 3017) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UPMC Cancer Center/Hillman Cancer Center ( Site 3017) conducted?

UPMC Cancer Center/Hillman Cancer Center ( Site 3017) has 1 clinical trials on record, with 1 currently active. Their work covers Carcinoma, Renal Cell.

Is UPMC Cancer Center/Hillman Cancer Center ( Site 3017) accredited by Crixeo Health?

UPMC Cancer Center/Hillman Cancer Center ( Site 3017) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UPMC Cancer Center/Hillman Cancer Center ( Site 3017)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.